Search

everythinglearnresearchcommunity

for

Search:↓

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Skin issues from testosterone therapy in transgender men can be managed with combined dermatology and endocrinology care.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Proteoglycan replacement therapy improved hair conditions in most patients with alopecia.

A woman developed male characteristics after using unregulated hormone therapy.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Thyrotropin-releasing hormone may help control skin and hair growth and could aid in treating related disorders.

Er:YAG laser therapy effectively treats Hailey-Hailey disease, leading to long-term remission and improved quality of life.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

A girl had rickets due to a gene mutation affecting vitamin D response.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

EREG therapy may help treat hair loss by promoting hair growth.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The Rigenera method improved hair thickness and reduced hair loss in patients.

Hormone replacement therapy can improve skin aging in postmenopausal women.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.